Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

Related Articles by Review for PubMed (Select 17901079)

1.

Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction.

Kastrati A, Dibra A, Spaulding C, Laarman GJ, Menichelli M, Valgimigli M, Di Lorenzo E, Kaiser C, Tierala I, Mehilli J, Seyfarth M, Varenne O, Dirksen MT, Percoco G, Varricchio A, Pittl U, Syvänne M, Suttorp MJ, Violini R, Schömig A.

Eur Heart J. 2007 Nov;28(22):2706-13. Epub 2007 Sep 27. Review.

2.

Drug-eluting stents versus bare-metal stents in diabetic patients with ST-segment elevation acute myocardial infarction: a pooled analysis of individual patient data from seven randomized trials.

Iijima R, Byrne RA, Dibra A, Ndrepepa G, Spaulding C, Laarman GJ, Menichelli M, Valgimigli M, Di Lorenzo E, Kaiser C, Tierala I, Mehilli J, Suttorp MJ, Violini R, Schömig A, Kastrati A.

Rev Esp Cardiol. 2009 Apr;62(4):354-64. Review. English, Spanish.

4.

Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials.

Piscione F, Piccolo R, Cassese S, Galasso G, Chiariello M.

Catheter Cardiovasc Interv. 2009 Aug 1;74(2):323-32. doi: 10.1002/ccd.22017. Review.

PMID:
19360858
5.
6.

The effect of drug-eluting stents on intermediate angiographic and clinical outcomes in diabetic patients: insights from randomized clinical trials.

Kumbhani DJ, Bavry AA, Kamdar AR, Helton TJ, Bhatt DL.

Am Heart J. 2008 Apr;155(4):640-7. doi: 10.1016/j.ahj.2007.11.017. Epub 2008 Feb 21. Review.

PMID:
18371470
7.

The efficacy of sirolimus- and paclitaxel-eluting stents: a meta-analysis of randomized controlled trials.

Kittleson MM, Needham DM, Kim SJ, Ravindran BK, Solomon SS, Guallar E.

Can J Cardiol. 2005 May 15;21(7):581-7. Review.

PMID:
15940356
8.

Meta-analysis of long-term outcomes for drug-eluting stents versus bare-metal stents in primary percutaneous coronary interventions for ST-segment elevation myocardial infarction.

Wallace EL, Abdel-Latif A, Charnigo R, Moliterno DJ, Brodie B, Matnani R, Ziada KM.

Am J Cardiol. 2012 Apr 1;109(7):932-40. doi: 10.1016/j.amjcard.2011.11.021. Epub 2012 Jan 3. Review.

PMID:
22221949
9.

A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease.

Schömig A, Dibra A, Windecker S, Mehilli J, Suárez de Lezo J, Kaiser C, Park SJ, Goy JJ, Lee JH, Di Lorenzo E, Wu J, Jüni P, Pfisterer ME, Meier B, Kastrati A.

J Am Coll Cardiol. 2007 Oct 2;50(14):1373-80. Epub 2007 Aug 21. Review.

10.
11.

Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials.

De Luca G, Dirksen MT, Spaulding C, Kelbaek H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, Díaz de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Cortese G, Suryapranata H, Stone GW; Drug-Eluting Stent in Primary Angioplasty (DESERT) Cooperation.

Arch Intern Med. 2012 Apr 23;172(8):611-21; discussion 621-2. doi: 10.1001/archinternmed.2012.758. Review.

PMID:
22529227
12.

Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction.

Pasceri V, Patti G, Speciale G, Pristipino C, Richichi G, Di Sciascio G.

Am Heart J. 2007 May;153(5):749-54. Review.

PMID:
17452148
13.

Drug-eluting stents for ST[corrected]-elevation acute myocardial infarction: do we need randomized trials?

Ryan J, Cohen DJ, Pinto DS.

Coron Artery Dis. 2006 Dec;17(8):667-71. Review. Erratum in: Coron Artery Dis. 2007 Mar;18(2):149.

PMID:
17119374
14.

Safety and efficacy of drug-eluting stents versus bare-metal stents in saphenous vein grafts lesions: a meta-analysis.

Sanchez-Recalde A, Jiménez Valero S, Moreno R, Barreales L, Lozano I, Galeote G, Martín Reyes R, Calvo L, Lopez-Sendon JL.

EuroIntervention. 2010 May;6(1):149-60. doi: 10.4244/. Review.

PMID:
20542811
15.

Clinical outcomes of dialysis patients after implantation of DES: meta analysis and systematic review of literature.

Athappan G, Ponniah T.

Minerva Cardioangiol. 2009 Jun;57(3):291-7. Review.

PMID:
19513010
16.

Drug-eluting stents for acute myocardial infarction.

Yeter E, Kurt M, Silay Y, Anderson HV, Denktas AE.

Expert Opin Pharmacother. 2009 Jan;10(1):19-34. doi: 10.1517/14656560802627952 . Review.

PMID:
19236180
17.

Stent choice in primary percutaneous coronary intervention: drug-eluting stents or bare metal stents?

Valgimigli M, Airoldi F, Zimarino M.

J Cardiovasc Med (Hagerstown). 2009 Oct;10 Suppl 1:S17-26. doi: 10.2459/01.JCM.0000362040.25767.f5. Review.

PMID:
19851216
18.

Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis.

Brar SS, Leon MB, Stone GW, Mehran R, Moses JW, Brar SK, Dangas G.

J Am Coll Cardiol. 2009 May 5;53(18):1677-89. doi: 10.1016/j.jacc.2009.03.013. Review.

19.

Drug-eluting versus bare metal stenting in acute myocardial infarction. A clinical review.

Jones WS, Washam JB, Meine TJ, Patel MR.

Minerva Cardioangiol. 2009 Oct;57(5):585-95. Review. Erratum in: Minerva Cardioangiol. 2009 Dec;57(6):830. Schuyler Jones, W [corrected to Jones, W S].

PMID:
19838149
20.

Meta-analysis of five randomized clinical trials comparing sirolimus- versus paclitaxel-eluting stents in patients with diabetes mellitus.

Zhang F, Dong L, Ge J.

Am J Cardiol. 2010 Jan 1;105(1):64-8. doi: 10.1016/j.amjcard.2009.08.652. Epub 2009 Nov 14. Review.

PMID:
20102892
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk